Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
MRK Coverage
Event
Merck & Co., Inc. (MRK) Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
Apr 13, 2026
Event
Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference
Apr 13, 2026
Event
Merck & Co., Inc. (MRK) Acquisition of Cidara Therapeutics By Merck
Apr 9, 2026
Transcript
Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Transcript
Feb 4, 2026
Transcript
Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Merck & Co., Inc. (MRK) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Key highlights from Merck’s (MRK) Q3 2025 earnings results
Oct 30, 2025
News
Infographic: How Merck (MRK) performed in Q3 2024
Oct 31, 2024